Advertisement
Screener

BIODESIX, INC. (BDSX) Beta

BIODESIX, INC. (BDSX) Beta

  • Beta · 5-year monthly: Value 0.59; Formula and calculation Saved five-year monthly beta; measures historical sensitivity to the benchmark..

Beta

Overview →

Financial period ending 2026-08-31; current quote 2026-08-31. Amounts retain their stated periods and units.

MetricValueFormula and calculation
Beta · 5-year monthly0.59Saved five-year monthly beta; measures historical sensitivity to the benchmark.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingBeta
2026-08-310.59

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45